| | WHEN NAMES MAKE CLAIMS: ETHICAL ISSUES IN MEDICAL DEVICE MARKETING Ethics & Medicine - Find Articles (Site not responding. Last check: ) |
 | | In the United States, the generic and trade names (also known as brand names) of pharmaceuticals are formally evaluated prior to marketing; however, there is no formal process of name analysis for medical device brand names (personal communication, US Food and Drug administration, 28 March 2003). |
 | | Generic drug names are created and assigned by the United States Adopted Names Council, which establishes logical nomenclature classifications based on pharmacological and/or chemical relationships (for example, angiotensin-converting-enzyme inhibitors end in "pril"). |
 | | The trade names of devices such as implants might very well be significant for patients, especially in the case of products which are life sustaining (e.g., pacemaker) and where such patients carry identification cards that are a daily reminder of the device name. |
| www.findarticles.com /p/articles/mi_qa4004/is_200407/ai_n9437144 (794 words) |